Acquired Amegakaryocytic Thrombocytopenic Purpura (AAMT) Case Series and
a single center experience
Abstract
Acquired Amegakaryocytic Thrombocytopenia is a rare hematologic
condition, with <50 cases reported. It is characterized by
severe thrombocytopenia with complete absence or severe reduction of
megakaryocytes in the bone marrow with otherwise normal hematopoiesis.
Its mechanism is not fully understood but is suggested to be related to
anti-thrombopoietin antibodies.